Leading sites in global networks of excellence
Link leading academic institutions, community sites, patients and care-givers, providers and payers in thousands of locations in more than 40 countries across US and Canada, Latin America, Europe, Africa, the Middle East, Australia and New Zealand, and Asia for investigation of new diagnostics, drugs and devices, and evaluation of clinical, economic and humanistic benefit.
From common disorders to rare diseases
Syreon excels not only in common therapeutic areas, but also in the advancing technologies of molecular sciences, stem cell transplantation and therapeutics, immune disease and immuno-oncology, and in the broader areas of organ failure, inflammatory disease and targeted therapy.
We complement our trials with companion studies to evaluate costs and develop pricing strategies, to support market access, and to monitor effective clinical use and economic value in today's competitive health environment.
Specialized resources for every need
Syreon provides the specialized research resources required for each particular research program from early phase PK / PD Phase 1/2a studies to at-home telemonitoring of cardiopulmonary function and other physiological parameters. We work with leading fully-accredited laboratories for specialized testing and communicate patient preferences and responses via rapid and simple ePRO applications.